Caroline Salas-Humara

Caroline Salas-Humara

Auto-generated profile, based on publicly available information

Caroline Salas-Humara

Department of Pediatrics, New York University School of Medicine, New York, New York

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 May 2007 in Neurology
Verified
Journal Article
Closed access
PDF file
HAH. Arif
H. Arif
RBR. Buchsbaum
R. Buchsbaum
DWD. Weintraub
D. Weintraub
SKS. Koyfman
S. Koyfman
CSC. Salas-Humara
C. Salas-Humara
LHL. J. Hirsch
L. J. Hirsch
Objective: To determine predictors and relative incidence of antiepileptic drug (AED)–related rash in patients taking all common AEDs.

1 December 2018 in Pediatrics
Verified
Journal Article
Closed access
PDF file
LKLaura L. Kimberly
Laura L. Kimberly
KFKelly McBride Folkers
Kelly McBride Folkers
PFPhoebe Friesen
Phoebe Friesen
DSDarren Sultan
Darren Sultan
GQGwendolyn Quinn
Gwendolyn Quinn
CSCaroline Salas-Humara
Caroline Salas-Humara
Transgender and gender-nonconforming (TGNC) youth who suffer from gender dysphoria are at a substantially elevated risk of numerous adverse physical and psychosocial outcomes compared with their cisgender peers. Innovative treatment options used to support and affirm an individual’s preferred gender identity can help resolve gender dysphoria and avoid many negative sequelae of nontreatment. Yet, despite advances in these relatively novel treatment options, which appear to be highly effective in addressing gender dysphoria and mitigating associated adverse outcomes, ethical challenges abound in ensuring that young patients receive appropriate, safe, affordable treatment and that access to this treatment is fair and equitable. Ethical considerations in gender-affirming care for TGNC youth span concerns about meeting the obligations to maximize treatment benefit to patients (beneficence), minimizing harm (nonmaleficence), supporting autonomy for pediatric patients during a time of rapid development, and addressing justice, including equitable access to care for TGNC youth. Moreover, although available data describing the use of gender-affirming treatment options are encouraging, and the risks of not treating TGNC youth with gender dysphoria are evident, little is known about the long-term effects of both hormonal and surgical interventions in this population. To support ethical decision-making about treatment options, we encourage the development of a comprehensive registry in the United States to track long-term patient outcomes. In the meantime, providers who work with TGNC youth and their families should endeavor to offer ethically sound, patient-centered, gender-affirming care based on the best currently available evidence.

15 November 2019 in Current Problems in Pediatric and Adolescent Health Care
Verified
Journal Article
Closed access
CSCaroline Salas-Humara
Caroline Salas-Humara
GSGina M. Sequeira
Gina M. Sequeira
WRWilma Rossi
Wilma Rossi
CDCherie Priya Dhar
Cherie Priya Dhar

1 December 2016 in Pediatric Clinics of North America
Verified
Journal Article
Closed access
SWSarah M. Wood
Sarah M. Wood
CSCaroline Salas-Humara
Caroline Salas-Humara
NDNadia L. Dowshen
Nadia L. Dowshen

1 December 2018 in Journal of Adolescent Health
Verified
Journal Article
Closed access
NLNellie Riendeau Lazar
Nellie Riendeau Lazar
CSCaroline Salas-Humara
Caroline Salas-Humara
SWSarah M. Wood
Sarah M. Wood
CMCynthia J. Mollen
Cynthia J. Mollen
NDNadia Dowshen
Nadia Dowshen

19 May 2021 in JMIR Research Protocols
Verified
Journal Article
Open access
MCMara Cohen
Mara Cohen
BKBaer Karrington
Baer Karrington
HTHoward Trachtman
Howard Trachtman
CSCaroline Salas-Humara
Caroline Salas-Humara
Background: A growing number of adolescents are coming out as transgender and gender expansive (TGE). These teenagers have been shown to have significantly worse health outcomes than their cisgender peers. Hypotheses to explain this discrepancy are based on increased stress levels surrounding the societal acceptance of gender identity. In this context, elevated allostatic load (AL), which describes the wear and tear sustained by the body in response to repeated exposure to stress, has been associated with adverse long-term health outcomes. Objective: This protocol aims to measure AL among TGE adolescents compared with their cisgender peers and assess how AL varies depending on psychological stress and perceived societal acceptance. Methods: This is an observational proof-of-concept pilot study in which AL will be measured by assaying an array of inflammatory cytokines and cortisol in urine, saliva, and hair samples of TGE youth, and these parameters will be compared with those of age-matched control participants. A questionnaire will assess 4 aspects of psychosocial well-being: presence and management of depression and anxiety, gender identity support by family members, gender minority stress, and degree of perceived safety in the surrounding community. Samples and surveys will be collected at 3 visits (baseline, 6 months, and 12 months). This study will incorporate TGE coinvestigators to inform all aspects of design, data collection, and analysis and ensure that practices are carried out in a respectful and sensitive manner. Results: As of May 2021, the start of data collection for this project has continued to be postponed as a result of the COVID-19 pandemic, which has both impacted the functioning of the clinic and funding requests. We hope to begin participant recruitment and interviews with coinvestigators soon. Conclusions: We hypothesize that AL will be primarily influenced by psychological well-being and perceived support and that it will be similar in TGE adolescents and in age-matched cisgender control participants when acceptance and perceived support are high. The results of this study have the potential to increase our understanding of the health challenges faced by TGE individuals during adolescence as well as to show that low levels of acceptance may have detrimental health outcomes secondary to elevated ALs; this may lead to the development of a biomarker profile to assess allostatic stress in TGE patients that can be used to guide management. International Registered Report Identifier (IRRID): PRR1-10.2196/24100